Advances and Emerging Trends in Diabetes Monitoring Technologies

Table of Contents

1 EXECUTIVE SUMMARY

• Research Scope and Methodology
  • Scope
  • Research Methodology
• Glucose Monitoring in Focus
  • Industry Overview
  • Noteworthy Developments

2 DIABETES MONITORING: TECHNOLOGY PRIMER

• Diabetes
  • The Disease Types and Prevalence
  • Human Social and Economic Impact of Diabetes
• Glucose Monitoring--A Technology Evaluation
  • Glucose: The Omnipresent Enemy
  • Glucose Monitoring: History to Chemistry
  • Noninvasive Glucose Monitoring--A Much-Awaited Reprieve
  • Overview of Noninvasives under Development

3 TECHNOLOGY ASSESSMENT ACROSS GEOGRAPHICAL REGIONS

• USA
  • A Minimally Invasive "Seven" Day Continuous Glucose Monitor
  • An Optical Coherence Tomography (OCT)-Based Device for Noninvasive Glucose Monitoring in the Hospital
  • A Surrogate Caregiver to Help Manage Diabetes
  • The First Home-Based Diabetes Risk Assessment Kit
  • World' s Smallest Dermal Microsensor for Continuous Glucose Monitoring
  • A Novel Biomarker and an Innovative Method to Noninvasively Diagnose Diabetes
• World
  • A Novel Technology Trio to Noninvasively Measure Glucose--Israel
  • Occlusion Spectroscopy-Based Method for Noninvasive Continuous Glucose Monitoring--Israel
  • A Novel Device to Warn Type 1 Diabetics of Nocturnal Hypoglycemia--Australia
  • A Low Cost Glucose Monitoring Product for Every Need--Australia

4 TECHNOLOGY ADOPTION FACTOR ANALYSIS

• Analysis of Growth Influencing Factors of Noninvasives
  • rowth Accelerators
  • Growth Decelerators
  • Major Challenges
• Assessment of the Regulatory and Reimbursement Scenario
  • The Regulatory Environment
  • The Health Insurance Scenario
• Assessment of Opportunity Galore in Blood Glucose Monitoring
  • A SWOT Analysis
  • Noninvasive Technologies--A Market Opportunity Analysis
• Strategic Recommendations and Analyst' s Insights
  • The In-betweeners: Minimally Invasive Monitoring
  • CGM: Analysis of Impact and Adoption Barriers
  • Strategic Recommendations to Stakeholders
  • Analysis of Prevailing and Future Industry Trends
  • Strategic Future Scenario Analysis: Analyst' s Insights

5 PATENT ANALYSIS AND CONTACT DETAILS

• Patents and Analysis
  • Analysis of Patents in Noninvasive Segment
  • Key Patents from North America
  • Key Patents from RoW
• Contact Details
  • Key Contacts in North America
  • Key Contacts in RoW

6 DECISION SUPPORT DATABASE

• Database Tables
  • Global Diabetes Prevalence--2002 to 2012
  • Global Diabetes Prevalence Percentage--2002 to 2012
  • Global Diabetes Incidence--2006 - 2012